Compare Novartis AG (NVS) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Zillow Group Inc Class A — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: Novartis AG is far larger — about 38.5× Zillow Group Inc Class A's market cap, and Novartis AG pays a 3.17% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.
| NVS | ZG | |
|---|---|---|
Market Cap | $290.25B | $7.54B |
Sector | Health | Media |
52-Week High | $168.62 | $86.76 |
52-Week Low | $113.50 | $29.14 |
Enterprise Value | $330.27B | $7.19B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
